News
-
-
-
PRESS RELEASE
GBC AG Initiates Coverage on Marinomed Biotech AG – Buy Recommendation with Price Target of EUR 42.00
GBC AG initiates coverage on Marinomed Biotech AG with a Buy recommendation and EUR 42.00 price target. Focus on innovative Marinosolv® technology for immunological and inflammatory diseases -
-
-
PRESS RELEASE
GBC AG initiates coverage on dynaCERT Inc. – Buy recommendation with a price target of CAD 0.75 (EUR 0.48)
GBC AG initiates coverage on dynaCERT Inc., a Canadian cleantech company, issuing a Buy recommendation with a price target of CAD 0.75 (EUR 0.48). The company has developed HydraGEN™, a solution for reducing CO₂ emissions and improving fuel efficiency in diesel engines -
-
-
-